Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.
about
Thrombin activation and liver inflammation in advanced hepatitis C virus infectionMicrocomputed tomography with diffraction-enhanced imaging for morphologic characterization and quantitative evaluation of microvessel of hepatic fibrosis in rats.Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complexHyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis.Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's disease.Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study.Impact of antithrombin III on hepatic and intestinal microcirculation in experimental liver cirrhosis and bowel inflammation: an in vivo analysis.Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics.Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease.Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis.Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases.The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm.Viral cirrhosis: an overview of haemostatic alterations and clinical consequencesCoagulation in hepatobiliary disease.New therapeutic paradigm for patients with cirrhosis.Review: Viral infections and mechanisms of thrombosis and bleeding.Management of portal vein thrombosis in liver cirrhosis.Future treatments of cirrhosis.VAP score as a novel non-invasive liver fibrosis model in patients with chronic hepatitis C.The association of non-O blood group and severity of liver fibrosis in patients with chronic hepatitis C infection.Role of anticoagulant therapy in liver disease.A role for thrombin in liver fibrosis.The hyperglycemic byproduct methylglyoxal impairs anticoagulant activity through covalent adduction of antithrombin III.Haemostatic Profile of Patients with Chronic Liver Disease- its Correlation with Severity and OutcomeEffects of aspirin and enoxaparin in a rat model of liver fibrosis.The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source.CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis.Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C.Coexistent Ipsilateral Internal Carotid Artery Occlusion and Cerebral Venous Thrombosis in Hepatitis C.Erythrocytic phosphatidylserine exposure and hemostatic alterations in β-thalassemia intermediate patients.von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.Benign external compression of the inferior vena cava associated with thrombus formation.Thrombin and factor Xa link the coagulation system with liver fibrosis.Protein C Deficiency in Chronic Hepatitis C: Correlation With Histological Extent of Liver Fibrosis.
P2860
Q26749460-0891BCA8-4C11-460B-9CC3-A90A42861768Q27303571-C34C929C-4682-48F6-B71E-EC7CA7163D46Q27478140-9E3E09E3-223C-469C-8636-4C252211643AQ34012609-F1E48595-174B-442C-9029-EDD1570E72B9Q34013076-63FBA12B-C4C0-4B72-8246-39386B247DC7Q34038709-9142A5F1-9D17-422A-A9AD-844812D03536Q35064494-6023D90E-6548-4ADA-B6A9-2CB88BAD4DFFQ35235447-587531F4-8EED-47C6-A367-162519DF3F82Q35597990-D942C47B-2FD7-4124-8F3E-57C76744CA82Q35613902-58FF6503-10D7-47FB-9370-B7AAE6910D37Q35777683-7182D0C5-1ECE-45CE-BEFC-73FD505AEE41Q35928746-2EED2764-5B04-4CF4-9E33-86BF4FE4FE6BQ37646912-E329F56E-4EB9-4728-A943-F54917C80F9DQ37854462-4738353D-C6E6-4BD0-AF58-78E879408D97Q37982415-654BB810-285B-45A7-8752-6F3FD43E13A9Q38021413-17FA091E-1DEF-45B1-B8E3-02072BFFCA01Q38038832-8E73CCF2-0280-4463-968F-9DFBB7C4B167Q38200854-56744E4A-CCE8-4DD9-8CC6-FAB7F37F7609Q38218607-03F0823C-ECB9-4E66-BCD4-9693004F6CEEQ38863591-CC8FB089-D2D7-4F4B-86B9-F1FB1A74F2E9Q40037618-7B08AE1C-B33E-49DB-8F0B-83861BD141E1Q40707344-B6739245-E0EA-4DEC-9F54-D24BE81ECA02Q41791167-B92EC329-8DAF-405A-BA16-E673D7243992Q41910544-C712515E-AF1A-450A-AE29-EFF741F290E9Q42367006-83D58E25-63B4-4308-92ED-2D60FFBAD63FQ42695257-62669A6B-E2AC-4F4A-9A86-8959B00C8546Q43036723-B3A9B96B-B4E3-4B9B-B127-0C19A25CB1B1Q43159403-E3D2B666-A248-4D0B-BC2C-6A1C4D0B9515Q44703656-0AAA2A16-52F8-40DF-B0C2-6B8B8CD8C6E4Q47551591-1678E3C3-7B76-4C45-9B94-649C2D3DA7ADQ50477058-78D80E0E-2B32-4DF6-9675-E59EFEDBE772Q51344051-72ABC9E1-3C90-475A-8DFA-ADC9A787D2A3Q53584306-1BB54076-28B7-4F43-8BDD-1BBB6B1B4E88Q54996240-B0B30599-D06E-4948-A422-1CB7DA28329EQ55059117-F5DE6870-07E8-4D05-8D0E-86CB60E5F845
P2860
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.
@ast
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.
@en
type
label
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.
@ast
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.
@en
prefLabel
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.
@ast
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.
@en
P2093
P2860
P356
P1433
P1476
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.
@en
P2093
E Andrioti
E Cholongitas
E Papakonstantinou
G V Papatheodoridis
I Kontopoulou
S J Hadziyannis
P2860
P304
P356
10.1136/GUT.52.3.404
P407
P577
2003-03-01T00:00:00Z